SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for HCPs
shingrixhcp.comSHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older. SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox). In the pivotal clinical trials in adults 50 years and older, the most common solicited adverse reactions observed were pain, redness, and swelling at ...
Shingrix Vaccine FAQs | CDC
www.cdc.gov › vaccines › vpdShingrix is recommended to prevent shingles and related complications in immunocompetent adults 50 years and older, and for adults 19 years and older who are or will be immunocompromised. Make every effort to ensure that two doses are administered within the recommended 2–6 month interval.